scholarly article | Q13442814 |
P2093 | author name string | J Scott Roberts | |
Cathleen M Connell | |||
Sara J McLaughlin | |||
P2860 | cites work | The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee | Q37549229 |
Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents | Q39660783 | ||
Public opinion about Alzheimer disease among blacks, hispanics, and whites: results from a national survey | Q40177052 | ||
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial | Q40494480 | ||
Illness representations among first-degree relatives of people with Alzheimer disease | Q40747344 | ||
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective | Q41366395 | ||
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease | Q44470398 | ||
Ethnically diverse older adults' beliefs about staying mentally sharp | Q46701518 | ||
Knowledge of Alzheimer's disease in four ethnic groups of older adults | Q46935971 | ||
Public attitudes about genetic testing for Alzheimer's disease | Q48664461 | ||
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. | Q50747108 | ||
Anticipatory dementia: a link between memory appraisals and concerns about developing Alzheimer's disease. | Q51110338 | ||
Racial differences in knowledge and beliefs about Alzheimer disease. | Q51635948 | ||
Perceived threat of Alzheimer disease (AD): the role of personal experience with AD. | Q51971993 | ||
Anti-aging quackery: human growth hormone and tricks of the trade--more dangerous than ever | Q28276539 | ||
Monetary costs of dementia in the United States | Q28288245 | ||
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use | Q28752562 | ||
The Health Belief Model: A Decade Later | Q29541592 | ||
Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members | Q34053221 | ||
Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions | Q34135724 | ||
2012 Alzheimer's disease facts and figures | Q34260109 | ||
Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics | Q35316963 | ||
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors | Q35889850 | ||
Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study | Q36790111 | ||
The projected effect of risk factor reduction on Alzheimer's disease prevalence | Q36825862 | ||
The Alzheimer's Disease Knowledge Scale: development and psychometric properties | Q37155273 | ||
The public's perceptions about cognitive health and Alzheimer's disease among the U.S. population: a national review | Q37518871 | ||
P433 | issue | 5 Suppl | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | S381-9 | |
P577 | publication date | 2014-03-14 | |
P1433 | published in | Alzheimer's and Dementia | Q15750965 |
P1476 | title | Public beliefs and knowledge about risk and protective factors for Alzheimer's disease | |
P478 | volume | 10 |
Q36719734 | A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status Disclosure |
Q41375501 | A qualitative study of older and middle-aged adults' perception and attitudes towards dementia and dementia risk reduction. |
Q41475171 | A study on knowledge, attitudes and health behaviours regarding Alzheimer's disease among community residents in Tianjin, China |
Q27345258 | Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results |
Q36303379 | Concern about developing Alzheimer's disease or dementia and intention to be screened: An analysis of national survey data |
Q37498154 | Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study |
Q48026852 | Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach. |
Q36638757 | Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials |
Q38758770 | Do Worries About Cognitive Functioning and Concerns About Developing Alzheimer's Disease Affect Psychological Well-Being? |
Q90273183 | Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial |
Q49859150 | Feasibility of an Alzheimer's disease knowledge intervention in the Latino community. |
Q57211374 | How Much Do Older Adults Living Alone in Rural South Korea Know About Dementia? |
Q38626734 | Long-term and short-term predictors of worries about getting Alzheimer's disease |
Q40507428 | Perceptions of Alzheimer's Disease in the French Population: Evolutions between 2008 and 2013 and Associated Factors in 2013. |
Q50421914 | Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals. |
Q46979138 | Racial/Ethnic and Nativity Differences in Cognitive Life Expectancies Among Older Adults in the United States. |
Q51759511 | The Impact of Creative Arts in Alzheimer's Disease and Dementia Public Health Education. |
Q40163132 | The Influence of Psychosocial and Cognitive Factors on Perceived Threat of Alzheimer's Disease |
Q58786623 | What Does the Australian General Public Know About Treatments for Dementia? A Population Survey |
Q52577945 | What does the general public understand about prevention and treatment of dementia? A systematic review of population-based surveys. |
Q41470987 | Worries about getting Alzheimer's: who's concerned? |
Search more.